Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Mvarr...ease...billw...

Jun 24, 2007 10:54AM

Jun 24, 2007 01:37PM

Jun 24, 2007 01:53PM

Interesting posts by each one of you. Thanks. The picture remains clear to me .

1. Licensure

2. CEO Strategy Development

3. NASDAQ

4. Insttutional/ Mutual Fund Buy In

I think it is really important to keep this focus. Why? Look at Iraq. We won the war but lost the peace because we did not plan for what was going to happen next and this should have happened prior to the first move of aggression toward Hussein. Lack of prior planning to reach your ultimate goal is foolhardy indeed. We do not have to know all the dirty steps and the bloody fights that are going to occur. We have to know and insist that our corporation knows the ultimate steps and that some discussion by investors takes place. Mr. Pohl insured this by establishing this Board for all members as the sounding board to the company. It is our responsibility to ask the tough questions.

Ron and many others have accomplished all this by the tough questions they have asked to keep the board on track. Our CEO ia a daredevil (no more racing Paul Newman) who will take the risks we need to take to make this company powerful. If this company has a great plan that it begins to execute, the powers to be in WallStreet will take notice and I think, Katie bar the doors. Licensure will get this company increased attention and a major jump in SP. CEO strategy and beginning execution will enhance attention. My concern is 3 and 4. Three should probably come with about due to (1) licensure and the explosion in stock price will come with (4). I believe S&L could be the catalyst for this. The question is am I right or wrong?


Jun 24, 2007 03:57PM

Jun 24, 2007 04:29PM

Jun 25, 2007 05:39AM

Jun 25, 2007 05:48AM

Jun 25, 2007 06:21AM

Jun 25, 2007 06:21AM
Share
New Message
Please login to post a reply